Nicole Urban

23.8k total citations · 4 hit papers
191 papers, 18.2k citations indexed

About

Nicole Urban is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Nicole Urban has authored 191 papers receiving a total of 18.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 49 papers in Reproductive Medicine and 46 papers in Molecular Biology. Recurrent topics in Nicole Urban's work include Ovarian cancer diagnosis and treatment (49 papers), Global Cancer Incidence and Screening (38 papers) and BRCA gene mutations in cancer (21 papers). Nicole Urban is often cited by papers focused on Ovarian cancer diagnosis and treatment (49 papers), Global Cancer Incidence and Screening (38 papers) and BRCA gene mutations in cancer (21 papers). Nicole Urban collaborates with scholars based in United States, South Africa and Germany. Nicole Urban's co-authors include Charles W. Drescher, Kathy O'Briant, Beatrice S. Knudsen, Muneesh Tewari, Rachael K. Parkin, Martin McIntosh, Stacia K. Wyman, Patrick S. Mitchell, Brian R. Fritz and Evan M. Kroh and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Nicole Urban

188 papers receiving 17.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating microRNAs as stable blood-based markers for cancer detection

2008 6.5k citations Patrick S. Mitchell, Rachael K. Parkin et al. Proceedings of the National Academy of Sciences profile →
The case for early detection

2003 902 citations Ruth Etzioni, Nicole Urban et al. profile →
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

2008 792 citations Wataru Sakai, Elizabeth M. Swisher et al. profile →
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

2003 582 citations Martin McIntosh, Charles W. Drescher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicole Urban United States	58	9.1k	7.1k	4.5k	2.4k	1.6k	191	18.2k
Andrew K. Godwin United States	79	13.4k 1.5×	5.2k 0.7×	6.0k 1.3×	2.8k 1.2×	2.8k 1.8×	386	22.4k
Andrew Berchuck United States	73	8.1k 0.9×	3.8k 0.5×	5.8k 1.3×	6.9k 2.8×	2.9k 1.8×	358	19.9k
Hys Ngan Hong Kong	68	6.9k 0.8×	3.4k 0.5×	4.1k 0.9×	4.1k 1.7×	1.3k 0.8×	521	21.5k
Matthias W. Beckmann Germany	60	3.6k 0.4×	2.9k 0.4×	3.8k 0.9×	2.6k 1.1×	1.4k 0.9×	654	15.3k
Bella Kaufman Israel	54	4.4k 0.5×	3.2k 0.5×	8.1k 1.8×	1.3k 0.6×	2.6k 1.6×	250	15.2k
Paul D.P. Pharoah United Kingdom	71	7.3k 0.8×	4.8k 0.7×	6.7k 1.5×	1.2k 0.5×	6.1k 3.8×	340	19.9k
Olufunmilayo I. Olopade United States	76	7.1k 0.8×	6.3k 0.9×	7.5k 1.7×	1.4k 0.6×	7.4k 4.7×	420	20.0k
Deepa Naishadham United States	21	8.1k 0.9×	4.6k 0.7×	8.0k 1.8×	1.0k 0.4×	1.0k 0.6×	26	22.7k
R. Kreienberg Germany	54	2.1k 0.2×	3.4k 0.5×	4.3k 1.0×	1.5k 0.6×	934 0.6×	434	10.6k
Peter H. Watson Canada	72	9.1k 1.0×	5.0k 0.7×	7.2k 1.6×	533 0.2×	3.4k 2.1×	259	19.5k

Countries citing papers authored by Nicole Urban

Since Specialization

Citations

This map shows the geographic impact of Nicole Urban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Urban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Urban more than expected).

Fields of papers citing papers by Nicole Urban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Urban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Urban. The network helps show where Nicole Urban may publish in the future.

Co-authorship network of co-authors of Nicole Urban

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Urban. A scholar is included among the top collaborators of Nicole Urban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Urban. Nicole Urban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stichel, Jan, et al.. (2024). Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity. Angewandte Chemie International Edition. 64(6). e202417786–e202417786.

Urban, Nicole, Sylvia Vanderheiden, Nicole Jung, et al.. (2023). Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide‐induced migration of primary macrophages. British Journal of Pharmacology. 180(21). 2736–2749. 13 indexed citations

Müller, Markus, Nicole Urban, Frank Zufall, et al.. (2022). BTDAzo: A Photoswitchable TRPC5 Channel Activator**. Angewandte Chemie International Edition. 61(36). e202201565–e202201565. 17 indexed citations

Keller, Marco, et al.. (2021). The ethoxycarbonyl group as both activating and protective group in N-acyl-Pictet–Spengler reactions using methoxystyrenes. A short approach to racemic 1-benzyltetrahydroisoquinoline alkaloids. Beilstein Journal of Organic Chemistry. 17. 2716–2725. 3 indexed citations

Müller, Martin, Yu‐Kai Chao, Ong Nam Phuong Nguyen, et al.. (2021). Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth. Cell chemical biology. 28(8). 1119–1131.e27. 44 indexed citations

Kobayashi, Makoto, Hiroyuki Katayama, Ehsan Irajizad, et al.. (2020). Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis. Cancers. 12(2). 485–485. 7 indexed citations

Büch, Thomas, Nicole Urban, Ulrike Weirauch, et al.. (2020). Restoration of MARCK enhances chemosensitivity in cancer. Journal of Cancer Research and Clinical Oncology. 146(4). 843–858. 12 indexed citations

Kögel, Alexander, Hermann Kalwa, Nicole Urban, & Michael Schaefer. (2019). Artifact‐free objective‐type multicolor total internal reflection fluorescence microscopy with light‐emitting diode light sources—Part I. Journal of Biophotonics. 12(11). e201900033–e201900033. 11 indexed citations

Miller, Chris P., Jason D. Thorpe, Tai-Hsien Ou Yang, et al.. (2014). JAK2 Expression Is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors. Cancer Immunology Research. 2(4). 301–306. 19 indexed citations

10.

Nörenberg, Wolfgang, Helga Sobottka, Nicole Urban, et al.. (2013). The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor. Neuropharmacology. 75. 365–379. 28 indexed citations

11.

Fischer, Wolfgang B., Nicole Urban, Kerstin Immig, Heike Franke, & Michael Schaefer. (2013). Natural compounds with P2X7 receptor-modulating properties. Purinergic Signalling. 10(2). 313–326. 25 indexed citations

12.

Drescher, Charles W., Sarah Hawley, Jason D. Thorpe, et al.. (2012). Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening. Cancer Prevention Research. 5(8). 1015–1024. 19 indexed citations

13.

Strauss, Robert, Pavel Sova, Ying Liu, et al.. (2009). Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses. Cancer Research. 69(12). 5115–5125. 57 indexed citations

14.

Swisher, Elizabeth M., Wataru Sakai, Beth Y. Karlan, et al.. (2008). Secondary BRCA1 Mutations in BRCA1 -Mutated Ovarian Carcinomas with Platinum Resistance. Cancer Research. 68(8). 2581–2586. 346 indexed citations

15.

Mitchell, Patrick S., Rachael K. Parkin, Evan M. Kroh, et al.. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences. 105(30). 10513–10518. 6512 indexed citations breakdown →

16.

Goff, Barbara A., Lynn S. Mandel, Charles W. Drescher, et al.. (2006). Development of an ovarian cancer symptom index. Cancer. 109(2). 221–227. 258 indexed citations

17.

Bast, Robert C., Nicole Urban, Viji Shridhar, et al.. (2002). Early Detection of Ovarian Cancer: Promise and Reality. Cancer treatment and research. 107. 61–97. 109 indexed citations

18.

Stoddard, Anne M., Barbara K. Rimer, Dorothy S. Lane, et al.. (1998). Underusers of Mammogram Screening: Stage of Adoption in Five U.S. Subpopulations. Preventive Medicine. 27(3). 478–487. 75 indexed citations

19.

Urban, Nicole, Stephen H. Taplin, Victoria M. Taylor, et al.. (1995). Community Organization to Promote Breast Cancer Screening among Women Ages 50-75. Preventive Medicine. 24(5). 477–484. 39 indexed citations

20.

Urban, Nicole, et al.. (1993). Effects on response rates and costs of stamps vs business reply in a mail survey of physicians. Journal of Clinical Epidemiology. 46(5). 455–459. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact